PLSMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Pulsenmore Ltd.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 30, 2026

$1.78−0.09 (-4.81%)

Close on Oct 19, 2026

Debt

Borrowings on the balance sheet, Jun 30, 2026

Pulsenmore reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Bond issues

Individual notes and bonds outstanding

Bond-level data is not connected yet

Coupon, maturity and amount of each note will come from the debt footnote in Pulsenmore's annual report. Trading prices and yields need FINRA TRACE data.

Where these numbers come from

Parsed from the XBRL in Pulsenmore's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is PLSM.

Revenue growth314.3% · median 12.7%

Gross margin84.2% · median 77.1%

Company	Revenue	Growth
CVRX	$61.19M	+12.0%
PLSM	40.02M ILS	+314.3%
UTMD	$36.11M	–
BWAY	$22.06M	-4.5%
PROF	$19.09M	+61.2%
BTCY	$16.40M	+13.4%

Company

Exchange: Nasdaq
Industry: Surgical & Medical Instruments & Apparatus
Fiscal year ends: December 31
Employees: 63
Auditor: Kesselman & Kesselman
SEC CIK: 2064764

Advertisement
300 × 250